There is nearly a half century of overwhelming evidence that agonist substitution, initially with methadone and more recently with buprenorphine and naltrexone, is both efficacious in clinical trials and effective in the community in promoting and sustaining abstinence and reducing risks associated with opioid dependence
This webinar will examine the largest such evaluation to date of extended-release naltrexone (XR-NTX) opioid treatment compared to a gold standard of care, buprenorphine maintenance, and discuss the relevance of the data to clinical practice.
Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
- General Member - Free
- Resident-Fellow Member - Free
- Medical Student Member - Free
- Non-Member - Free
- Describe the aims and methods of the X:BOT trial.
- Compare XR-NTX vs. BUP-NX effects on relapse-free survival, opioid use rates, and overdose events.
Physicians who have a waiver to treat opioid use disorder in an office-based setting and other interested clinicians.
Estimated Time to Complete
Estimated Duration: 1 hour
Begin Date: July 31, 2018
End Date: July 31, 2021
How to Earn Credit
Participants who wish to earn AMA PRA Category 1 Credit™ or a certificate of participation may do so by completing all sections of the course including the evaluation. A multiple-choice quiz is provided based on the content. A passing score of 100% must be achieved. Retakes are available for the test. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the completion date and hours earned.
Continuing Education Credit
The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Planner Disclosures
- Joshua D. Lee, M.D., NYU Langone Health, Reports no finanical relationships with commercial interests
- John A. Renner, Jr., M.D., Boston University School of Medicine, Director, Addiction Psychiatry Residency Training, Boston University Medical Center and VA Boston Healthcare System. Disclosure: Stockholder: Johnson & Johnson and General Electric.
- Eunice Maize, American Psychiatric Association. Reports no finanical relationships with commercial interests
- Tristan Gorrindo,M.D., American Psychiatric Association, Reports no finanical relationships with commercial interests
Optimal System Configuration:
- Flash Player: Adobe Flash Player 10.3+
- Browser: Firefox (latest version), Internet Explorer 8.0+, Safari 7.0+, Microsoft Edge (latest version) or Google Chrome (latest version)
- Operating System: Windows XP+ or Mac OS X 10.4+
- Internet Connection: 1 Mbps or higher
- Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Macromedia Flash Player 10.3 or higher; Sound Card at least 16-bit; audio playback with speakers for programs with video content
- Macintosh:Mac OS X 10.4+ or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit; audio playback with speakers for programs with video content
For assistance: Contact firstname.lastname@example.org for questions about this course | Contact email@example.com for technical assistance
All materials copyright American Psychiatric Association. ©2018